Research team
Expertise
I am a researcher in radiopharmaceutical sciences with expertise in radiochemistry, medicinal chemistry, and molecular imaging. My work focuses on the design, synthesis, and radiolabeling of small molecules, peptides, and antibodies with diagnostic and therapeutic radionuclides (e.g., 18F, 125I, 211At). I have experience in structure–activity relationship studies, the development of theranostic pairs, and the integration of drug-like properties to improve tracer stability and pharmacokinetics. Using advanced analytical tools such as HPLC, LC-MS, TLC, and gamma spectrometry, I ensure rigorous quality control and compliance with Good Manufacturing Practice (GMP) standards for clinical translation. My expertise also covers preclinical and translational imaging (PET, SPECT, and hybrid modalities), quantitative image analysis, radiation dosimetry, and in vivo evaluation in disease models. Through interdisciplinary collaboration across chemistry, biology, nuclear medicine, and oncology, I contribute to the development of innovative tracers and theranostic agents for oncology and neurology.